Publications by authors named "Pascal Goetghebeur"

Claim this Profile
C
Correction to: Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
Rosa Fradley, Pascal Goetghebeur, David Miller, Russell Burley, Sarah Almond

Neurochem Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
Rosa Fradley, Pascal Goetghebeur, David Miller, Russell Burley, Sarah Almond

Neurochem Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia.
Roger S McIntyre, David G Daniel, Eduard Vieta, István Laszlovszky, Pascal J Goetghebeur

CNS Spectr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer's Disease.
Wayne Chadwick, Stuart Maudsley, William Hull, Enes Havolli, Eugene Boshoff, Pascal J D Goetghebeur

Int J Mol Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia.
Pascal J D Goetghebeur, Keith A Wesnes, Steven D Targum

J Alzheimers Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial recognition test: A novel cognition task for assessing topographical memory in mice.
Enes Havolli, Mark Dw Hill, Annie Godley, Pascal Jd Goetghebeur

J Psychopharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence.
Pascal Jd Goetghebeur, Jina E Swartz

J Psychopharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin reverses the attentional set-shifting impairment in a rodent schizophrenia disease-like model.
Pascal Jean Denis Goetghebeur, Linda Lerdrup, Anders Sylvest, Rebecca Dias

Psychopharmacology (Berl)· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
Christian Spang Pedersen, Pascal Goetghebeur, Rebecca Dias

J Neurosci Methods· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study.
Pascal Goetghebeur, Rebecca Dias

Psychopharmacology (Berl)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis